52 Week Range
As of on the Euronext Paris ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
GrandVision Confirms EssilorLuxottica Taken Measures To Secure Certain Information
Essilorluxottica H1 Adjusted Operating Profit Down At EUR 126 Mln
Essilorluxottica: acknowledges arbitration from HAL and GrandVision and carries on with legal proceedings against them
EssilorLuxottica SA, formerly known as Essilor International Compagnie Generale D Optique SA, is a France-based ophthalmic company. The Company designs, manufactures and markets a range of lenses, frames and sunglasses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals. It operates through three segments: Lenses and Optical Instruments, which includes corrective lenses, optical instruments intended for opticians and optometrists; Equipment, which includes machines and consumables used by plants and prescription laboratories, and Sunglasses & Readers, which encompasses non-prescription reading glasses and non-prescription sunglasses. The Company operates under a number of brands, including Ray-Ban, Oakley and Varilux, among others. The Company operates in Europe, North America, Asia Pacific, the Middle East, Africa and Latin America.
Medical Equipment & Supplies
147 rue de Paris
Leonardo Del Vecchio
Executive Chairman of the Board
Executive Vice Chairman of the Board
Co-Chief Financial Officer
Co-Chief Financial Officer
Paul du Saillant
Chief Executive Officer of Essilor, Non-independent director
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
EssilorLuxottica <ESLX.PA> said on Monday that GrandVision's <GVNV.AS> actions during the coronavirus crisis could provide grounds for ending its 7.2 billion euro ($8.5 billion) takeover of the Dutch eyewear stores operator.
EssilorLuxottica said on Monday that GrandVision's actions during the coronavirus crisis could provide grounds for ending a 7.2 billion euro ($8.5 billion) takeover of the Dutch eyewear stores operator.
Oakley and Ray-Ban maker EssilorLuxottica's <ESLX.PA> second-quarter revenue almost halved due to store closures to curb the spread of the coronavirus, it said on Friday, sending operating profit tumbling by more than 90%.
Oakley and Ray-Ban eyewear maker EssilorLuxottica reported a 46% fall in second-quarter revenue on Friday, as a gradual recovery in May and June did not offset the impact of store closures to curb the spread of the coronavirus.
GrandVision<GVNV.AS>, the Dutch operator of a chain of eyeglass stores, said on Thursday it had started an arbitration case against its would-be buyer EssilorLuxottica to ensure the French-Italian eyeglass firm "complies with its obligations."
EU antitrust enforcers have temporarily halted an investigation into Ray-Ban maker EssilorLuxottica's <ESLX.PA> 7.2 billion euro (6.54 billion pounds) bid for Dutch optician group GrandVision, a filing on the European Commission website showed on Thursday.
The district court of Rotterdam on Monday said it would hear the case that EssilorLuxottica <ESLX.PA> has filed against its acquisition target GrandVision <GVNV.AS> on August 10.
EssilorLuxottica <ESLX.PA> has filed a legal action to obtain information from its acquisition target GrandVision <GVNV.AS> about its management of the coronavirus crisis, the French-Italian maker of Ray-Ban said on Saturday.
EssilorLuxottica has filed a legal action to obtain information from its acquisition target GrandVision about its management of the coronavirus crisis, the French-Italian maker of Ray-Ban said on Saturday.
EU antitrust authorities have extended their investigation into Ray-Ban maker EssilorLuxottica's 7.2 billion euro (6.5 billion pounds) bid for Dutch opticians group GrandVision by a week to Aug. 27.
EU antitrust authorities have extended their investigation into Ray-Ban maker EssilorLuxottica's <ESLX.PA> 7.2-billion-euro ($8.1 billion) bid for Dutch opticians group GrandVision by a week to Aug. 20.
EU regulators are set to warn Ray-Ban maker EssilorLuxottica that its 7.2 billion euro ($8.1 billion) bid for opticians group GrandVision may harm competition, people familiar with the matter said, pressuring the group to offer concessions.
EU antitrust regulators will warn EssilorLuxottica that its 7.2-billion-euro ($8.1 billion) bid for Dutch opticians group GrandVision could harm competition, people familiar with the matter said on Thursday.
EU antitrust regulators have set a new deadline of Aug. 13 for their decision on Ray-Ban maker EssilorLuxottica's <ESLX.PA> 7.2-billion-euro ($7.8 billion) bid for Dutch opticians group GrandVision <GVNV.AS>, a European Commission filing shows.
Oakley and Ray-Ban maker EssilorLuxottica <ESLX.PA> reported a slump in first-quarter sales on Tuesday and warned of an even bigger hit in the current quarter as the coronavirus outbreak prompted store closures.
* GOOD RESISTANCE FOR THE FIRST QUARTER WITH REVENUE DOWN 10%, TAKING MEASURES TO CONTROL COSTS AND PRESERVE CASH & PREPARING FOR RECOVERY AND DELIVERING ON OUR RESPONSIBILITIES TO ALL
Oakley and Ray-Ban maker EssilorLuxottica <ESLX.PA> said on Monday it would scrap its dividend and might also consider cost cuts as the coronavirus pandemic chokes its business.
EssilorLuxottica, the spectacles company whose brands include Oakley and Ray-Ban, said on Monday that it would scrap its dividend and would look to cut costs, in order to cope with the hit to its business from the coronavirus.
* ESSILORLUXOTTICA: LAURENT VACHEROT RETIRES & PAUL DU SAILLANT TO STEP IN AT ESSILORLUXOTTICA
Ray-Ban maker EssilorLuxottica <ESLX.PA> is suspending its dividend due to the coronavirus pandemic and said on Monday it was delaying its annual shareholder meeting by a month.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.